找到7记录 | 不满意,请使用左下搜索矩阵
排序: 相关性 发表日期 影响因子


Clinical management of chronic lymphocytic leukaemia (CLL) in patients aged ≥80 years is based on...

关键词: CLL    chemoimmunotherapy    chemotherapy    co-morbidity    elderly   
期刊:Br J Haematol  影响因子:5.206  发表日期: 20181201  PMID: 30460980 


Although trisomy 12 (+12) chronic lymphocytic leukemia (CLL) comprises about 20% of cases, relati...

期刊:Haematologica  影响因子:7.57  发表日期: 20181201  PMID: 29976738 


MOTIVATION: Clonal heterogeneity is common in many types of cancer, including chronic lymphocytic...

关键词:   
期刊:Bioinformatics  影响因子:4.531  发表日期: 20190901  PMID: 30689715 


关键词:   
期刊:Bioinformatics  影响因子:4.531  发表日期: 20190602  PMID: 31161200 


We report a randomized prospective phase 3 study (CLL7), designed to evaluate the efficacy of flu...

关键词:   
期刊:Leukemia  影响因子:9.944  发表日期: 20200218  PMID: 32071431 


BACKGROUND: Fludarabine, cyclophosphamide, and rituximab (FCR) has become a gold-standard chemoim...

背景:氟达拉滨,环磷酰胺和利妥昔单抗(FCR)已成为慢性淋巴细胞性白血病患者的金标准化学免疫疗法。但是,仍然存在如何治疗未治疗的IGHV未突变的慢性淋巴细胞性白血病的患者的问题。因此,我们旨在开...

关键词:   
期刊:Lancet Oncol  影响因子:35.386  发表日期: 20190930  PMID: 31582354 


    相关搜索: